Novo Nordisk’s Ozempic (Image: Joel Saget/AFP/Getty Images Show Quick Read Summary is AI Generated. Newsroom Reviewed

Danish drugmaker Novo Nordisk has launched its blockbuster diabetes drug Ozempic in India on Friday, Dec. 12, pricing the lowest dose of 0.25 mg at Rs 2,200 per week. As per Vikrant Shrotriya, MD, Novo Nordisk India, the pharmaceutical giant aims to hit the 'India-tailored pricing' with its once-weekly injectable formulation of semaglutide for Ozempic.

In an exclusive interaction with NDTV Profit, Shrotriya said that India deserves innovational and international quality standards for treatment of obesity and diabetes . With this launch, Ozempic now available in India as a once-weekly injectable formulation of semaglutide. It will be available in a pen format in

See Full Page